Live tape
Top 8, mentions 7d10,089GOOGL2,071 mentions▲ +0.04HTZ1,682 mentions▲ +0.10NBIS1,356 mentions▲ +0.10SPCX1,348 mentions▲ +0.08SNDK1,118 mentions▲ +0.11NVDA1,065 mentions▲ +0.08MSFT768 mentions▲ +0.06QQQ681 mentions▲ +0.08

Equity · Healthcare

STEK

Stemtech Corporation · OTC Markets OTCID

Price · Chart

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for STEK to draw a line in its place.

Track this symbol on TradingView

The chart above plots the price of STEK over the range selected — one day to the full history — drawn by TradingView from their own data.

Filings 3 sets

STEK reported financials

SEC EDGAR XBRL

STEK reported revenue of $2.9M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$4.0M.

Figure Reported Period
Revenue $2.9M 31 Dec 2025 fiscal year
Net income −$4.0M 31 Dec 2025 fiscal year
Diluted EPS −$0.02 31 Dec 2025 fiscal year
Total assets $3.2M 30 Jun 2026 at period end
Total equity −$7.5M 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

STEK earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $0.00 —
31 Mar 2026 Q1 2026 $0.00 —
31 Dec 2025 FY 2025 $-0.02 —
30 Sep 2025 Q3 2025 $-0.01 —
30 Jun 2025 Q2 2025 $0.00 —
31 Mar 2025 Q1 2025 $-0.01 —
31 Dec 2024 FY 2024 $-0.03 —
30 Sep 2024 Q3 2025 $-0.01 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

STEK fails-to-deliver

SEC CNS data

On 14 Jul 2026, 4,102,117 shares of STEK failed to deliver.

Settlement date Shares failed Notional % of shares out
14 Jul 2026 4,102,117 0.173%
09 Jul 2026 3,055,449 0.129%
08 Jul 2026 3,050,849 0.129%
06 Jul 2026 1,080,906 0.046%

Source: SEC fails-to-deliver (CNS) data